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Abstract
Background: Migrating leukocytes normally have a polarized morphology with an actin-rich lamellipodium at the front and
a uropod at the rear. Microtubules (MTs) are required for persistent migration and chemotaxis, but how they affect cell
polarity is not known.
Methodology/Principal Findings: Here we report that T cells treated with nocodazole to disrupt MTs are unable to form a
stable uropod or lamellipodium, and instead often move by membrane blebbing with reduced migratory persistence.
However, uropod-localized receptors and ezrin/radixin/moesin proteins still cluster in nocodazole-treated cells, indicating
that MTs are required specifically for uropod stability. Nocodazole stimulates RhoA activity, and inhibition of the RhoA
target ROCK allows nocodazole-treated cells to re-establish lamellipodia and uropods and persistent migratory polarity.
ROCK inhibition decreases nocodazole-induced membrane blebbing and stabilizes MTs. The myosin inhibitor blebbistatin
also stabilizes MTs, indicating that RhoA/ROCK act through myosin II to destabilize MTs.
Conclusions/Significance: Our results indicate that RhoA/ROCK signaling normally contributes to migration by affecting
both actomyosin contractility and MT stability. We propose that regulation of MT stability and RhoA/ROCK activity is a
mechanism to alter T-cell migratory behavior from lamellipodium-based persistent migration to bleb-based migration with
frequent turning.
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Introduction
Cell migration is essential for the recruitment of T cells to and
circulation within lymphoid organs, where they encounter
antigen-presenting dendritic cells, and in tissues during immune
surveillance, immune responses and inflammation. Migrating T
cells are normally morphologically polarized with spatially distinct
front (lamellipodium) and rear (uropod) structures, and migrate by
extending the lamellipodium forwards and retracting the uropod
[1–3]. In lymph nodes in vivo, T cells migrate rapidly and for
many hours until they encounter antigen [4]. In vitro, T cells
polarize spontaneously, for example on the integrin ligand ICAM-
1 [3], and this requires activation of the integrin LFA-1 [5].
Similarly, neutrophils polarize and migrate in a uniform
concentration of chemokine [6,7], a process that has been termed
‘‘self-organizing polarity’’ [8,9].
Cell polarization and migration require dynamic rearrangement
of the actin and microtubule cytoskeletons via intracellular
signaling pathways involving Rho family GTPases [10–12].
Lamellipodium extension in T cells requires Rac-induced actin
polymerization [13], whereas the uropod is enriched in cell
adhesion molecules such as ICAM-3 and CD44 that associate with
ezrin/radixin/moesin (ERM) proteins, which in turn link these
receptors with the cortical actin cytoskeleton [14]. Rho signaling is
required for uropod extension and for detachment of the rear of
migrating T cells [3,15]. Rho is also well known to stimulate
myosin light chain (MLC) phosphorylation and hence actomyosin
contractility [16].
Disruption of MTs by MT depolymerizing agents such as
nocodazole affects cell polarity and directional lamellipodium
extension in several cell types, including neutrophils [7,17–21], but
the effects of MT depolymerization on T cell migration have not
been studied in detail [22,23]. In migrating T cells, the
microtubule-organizing center (MTOC) is positioned behind the
nucleus and MTs are predominantly localized in the uropod,
which has been proposed to facilitate deformability of T cells [23].
In contrast, MTs and the MTOC polarize towards an antigen-
presenting cell during formation of an immune synapse [13].
Rho GTPases both regulate and are regulated by MT
dynamics. For example, MT depolymerization by nocodazole
has been shown to activate RhoA, in part through release of the
MT-associated RhoGEF, GEF-H1 [24,25]. On the other hand,
RhoA acts via its target mDia to mediate lysophosphatidic acid-
induced MT stabilization at the edge of a scratch wound in
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Rac1 promotes microtubule growth at the leading edge of
migrating cells through its target PAK1, which phosphorylates
and inhibits the MT-destabilising protein Op18/stathmin [29].
Here, we investigate the inter-relationship between MTs and
Rho signaling in T cell migration. We find that MT disruption
results in frequent turning of cells during migration, reflecting loss
of a stable uropod structure and increased membrane blebbing.
Inhibition of ROCK serine/threonine kinases, which are RhoA
targets, increases MT stability, inhibits blebbing and restores
migratory polarity, indicating that RhoA/ROCK signaling
regulates both contractility and MT dynamics during migration.
Results
Microtubules Are Required for Migratory Persistence of T
Cells
Stimulation of CCRF-CEM T cells with the chemokine
CXCL12/SDF-1a rapidly induced migratory cell polarity, with
a lamellipodium at the front and uropod at the back, and
migration on ICAM-1 (Figure 1A, B, Movie S1). To study the
contribution of MTs to T cell polarization and migration, cells
were treated with MT stabilizing (taxol) or depolymerizing
(nocodazole) reagents. Taxol prevented morphological polariza-
tion and migration on ICAM-1, and the majority of cells remained
stationary with a spherical morphology (Figure 1A, B, Movie S2).
In contrast, nocodazole did not significantly affect migration
speed, but caused unstable polarity and frequent turning
(Figure 1A, B, Movie S3). Most nocodazole-treated cells also did
not form a stable uropod structure which could dictate the axis of
migration. Instead, small uropod-like protrusions formed only
transiently and then retracted (Movie S3). The microtubule-
depolymerizing agent colchicine similarly induced loss of T cell
lamellipodial/uropod migratory polarity (data not shown).
High-resolution analysis by timelapse microscopy indicated that
nocodazole-treated cells often extended blebbing membrane
protrusions rather than lamellipodia (Figure 1C, D, Movies S4
and S5). Sequential membrane blebs could extend in one region of
the plasma membrane, allowing the cell to move progressively in
one direction, accompanied by cytoplasmic flow towards the
blebbing area (Figure 1D, Movie S5). Similar membrane blebbing
was also observed in nocodazole-treated human T-lymphoblasts
(Movies S6 and S7), indicating that this response is not restricted to
CCRF-CEM cells.
Microtubules Regulate T Cell Migratory Polarity
The effects of taxol and nocodazole on T cell migratory polarity
were quantified by analysing F-actin and a-tubulin distribution.
Prior to CXCL12 stimulation, CCRF-CEM cells did not have a
polarized distribution of F-actin, but CXCL12 rapidly induced F-
actin accumulation at one side of the cell, representing a single
lamellipodium, and cell elongation (Figure 2, Figure 3A). Most
MTs and the microtubule-organizing centre (MTOC) were
located behind the nucleus in the uropod of migrating CCRF-
CEM T cells, consistent with previous studies in neutrophils and T
cells (Figure 2) [7,20,23,30,31]. CXCL12-stimulated cell elonga-
tion and polarization was inhibited by taxol (Figure 2, Figure 3A),
although lamellipodia and membrane ruffles were often observed
around the circumference of taxol-treated cells in response to
CXCL12 (Figure 2). Nocodazole-treated cells were frequently
elongated but did not show the characteristic migratory polarity of
T cells (Figure 2, Figure 3A). Instead, F-actin often accumulated in
multiple small bleb-like protrusions in both unstimulated and
CXCL12-stimulated cells (Figure 2, nocodazole-treated cells,
indicated with arrows), in agreement with the membrane blebbing
observed by timelapse microscopy (Figure 1C, Movie S5).
Recently, it has been reported that F-actin accumulates in
membrane blebs as they start to retract [32], and thus it is likely
that these F-actin-enriched protrusions represent retracting blebs.
F-actin levels were increased in nocodazole-treated T cells
(Figure 3B), similar to observations that nocodazole increases F-
actin levels in neutrophils [20] and induces stress fibers in
fibroblasts [33].
Nocodazole Does Not Prevent Polarized Distribution of
Uropod Proteins
When leukocytes start to polarize, uropod-associated proteins
first cluster on the plasma membrane prior to uropod protrusion
[34]. The effect of nocodazole on cell polarity was investigated
further by studying the localization of uropod-enriched proteins,
including ICAM-3 [35,36] and C-terminally phosphorylated
ezrin-radixin-moesin proteins (phospho-ERMs) [15,35,37,38]. In
the majority of resting control cells, the distribution of ICAM-3
(Figure 4A) and phospho-ERMs (Figure 4B) was not polarized,
whereas following CXCL12 stimulation, ICAM-3 and phospho-
ERMs were predominantly localized in the uropod (Figure 4A, B).
CXCL12 stimulation induced diametric distribution of F-actin
and ICAM-3 to the leading edge and uropod respectively
(Figure 4A). Although migratory polarization was impaired by
taxol and nocodazole (Figure 1 and 2), in approximately 80% of
nocodazole-treated cells ICAM-3 was concentrated in one small
patch of the membrane regardless of CXCL12 stimulation
(Figure 4A). Some cells had a small ICAM-3-containing uropod
(Figure 4A, asterisks). Similar focal accumulation of the uropod
marker CD44 [35,39] was also observed in nocodazole-treated
cells (Figure S1A, asterisk). In addition, the strongest staining of
phospho-ERMs was often observed in a small patch or uropod-like
protrusion (Figure 4B, asterisks). RhoA localization on the plasma
membrane was higher in these patches of phospho-ERM
accumulation in nocodazole-treated cells (Figure 4B), consistent
with a link between RhoA and ERM phosphorylation [15,38].
Interestingly, RhoA localized at the plasma membrane in both the
uropod and lamellipodium of polarized untreated cells (Figure 4B:
control+CXCL12), suggesting it could function in both locations.
Phospho-ERMs also localized on bleb-like protrusions
(Figure 4B, arrows), in concordance with the observation that
ezrin gets recruited to retracting blebs [32]. ICAM-3 and CD44
were not localized in these bleb-like protrusions, ruling out the
possibility that they are small uropods (Figure 4A, Figure S1A,
arrows). MT depolymerization therefore does not prevent
polarized accumulation of uropod proteins. Despite this, nocoda-
zole-treated cells could not form a stable uropod.
Microtubules Regulate RhoA and ROCK Activity in T Cells
Nocodazole has previously been reported to induce an increase
in RhoA activity in several cell types [40]. Similarly, RhoA activity
was strongly increased in CCRF-CEM cells by 20 mM nocodazole
(Figure 5A). To determine whether MT depolymerization directly
regulates RhoA activity, cells were treated with taxol alone or with
taxol before nocodazole. Taxol alone did not affect RhoA activity,
but it completely blocked nocodazole-induced RhoA activation
(Figure 5A). MT depolymerization therefore triggers RhoA
activation in T cells.
CXCL12 stimulation of control T cells on ICAM-1 induced a
small but reproducible increase in active GTP-bound RhoA at
between 15 and 30 min (Figure 5B), similar to observations in Peer
T cells, PBL and Jurkat cells [30,41]. Interestingly, the high RhoA
activity in nocodazole-treated cells was slightly decreased upon
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PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8774Figure 1. Microtubule dynamics are required for stable T cell migratory polarity. CCRF-CEM T cells were pre-treated with or without 10 mM
taxol for 30 min or 20 mM nocodazole for 10 min, plated on ICAM-1-coated dishes, and stimulated with 1 nM CXCL12. Cell migration was monitored
by time-lapse microscopy. (A) Frames from movies of control, taxol or nocodazole-treated CCRF-CEM cells at 0, 4 and 8 min are shown. Outlines of
the cells at 0 (gray), 4 (yellow) and 8 (red) min reveal the migrating paths. Bars=10 mm. (B) Migration tracks of cells (10 to 16 cells for each condition)
are displayed as direction plots. The mean migration speed of cells 6 SEM is shown. Data shown are representative of 4 independent experiments. (C)
Frames of a nocodazole-treated CCRF-CEM cell (Movie S8). White arrowheads indicate bleb-like protrusions. (D) Frames of a control (top panels; Movie
S4) and nocodazole-treated (bottom panels; Movie S5) CCRF-CEM cell are shown. Right panels show kymographs of the region marked by the white
bar in the left panels. White arrows (bottom panel) indicate extension of progressive blebs. Bar=10 mm.
doi:10.1371/journal.pone.0008774.g001
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Rac (which is activated by CXCL12 [42]) on RhoA [43,44].
RhoA activates the serine/threonine kinases ROCK1 and
ROCK2 [16]. One of the targets of ROCKs is LIMK, which
phosphorylates and inactivates the actin-depolymerizing factor
cofilin. Cofilin phosphorylation was increased by CXCL12 or by
nocodazole (Figure 5C), correlating with the increases in RhoA
activity, and was reduced by an inhibitor of ROCK1 and
ROCK2, Y-27632 [45], consistent with cofilin being a down-
stream target of ROCK [46].
ROCK Inhibition Restores Migratory Persistence and
Chemotaxis to Nocodazole-Treated T Cells
The observation that nocodazole activates the RhoA/ROCK
signaling pathway led us to examine whether inhibition of ROCKs
could affect the migratory behaviour of nocodazole-treated cells.
Cells pre-treated with Y-27632 before nocodazole addition
migrated more persistently than cells treated only with nocodazole,
and their displacement (start-end distance) was increased
(Figure 6A, B), although total distance moved (length of track)
was not affected. Y-27632 alone caused a small reduction in
migration speed and cell trajectories were straighter than those of
control cells (Figure 6A). In contrast, Y-27632 did not affect the
migration speed of nocodazole-treated cells significantly
(Figure 6A).
Consistent with our observation that nocodazole reduces
migratory persistence, nocodazole decreased chemotaxis of
CCRF-CEM cells towards CXCL12 in transwell assays
(Figure 6C). This inhibition of chemotaxis by nocodazole was
rescued by co-treatment with Y-27632, in agreement with its
ability to rescue migratory persistence as determined from
timelapse movies (Figure 6B).
ROCK Inhibition Prevents Blebbing and Restores
Migratory Polarity in Nocodazole-Treated Cells
ROCK has been reported to localize predominantly to the
uropod in polarized human T cells [3], and Y-27632 induced
elongated protrusions at the uropod enriched in MTs [30]. We
therefore speculated that Y-27632 might restore T cell migration
by rescuing a stable uropod structure in nocodazole-treated cells.
Addition of Y-27632 during the acquisition of timelapse movies
inhibited membrane blebbing and successfully re-established stable
uropods in nocodazole-treated cells, allowing cells to move
persistently in one direction (Figure 6D, indicated with white
arrows, Movies S8 and S9). In addition, Y-27632 restored
lamellipodial ruffling at the leading edge (Figure 6D, indicated
with white arrowhead, and Movie S9). As previously reported for
human PBLs, eosinophils and monocytes [3,47,48], the uropod
often became elongated in Y-27632-treated cells into a long tail
that remained attached to the substratum while the cell body with
a ruffling leading edge continued to move forward (Figure 6D
from 20 min to 22 min in nocodazole-treated cells indicated with
white arrows, and Movies S9, S11, S12). However, the tail
eventually retracted in most cases, allowing the cell to move
persistently (Movies S10, S11, S12). Similarly, Y-27632 restored
lamellipodial/uropod migratory polarity to colchicine-treated cells
(data not shown). Together, these data indicate that inhibition of
ROCKs rescues the polarity and migration of T cells treated with
MT depolymerizing agents.
Microtubules and ROCKs Have Similar Effects on
Endothelial Migration
To determine whether the effects of MT depolymerization and
ROCK inhibition on cell migration were similar in a different cell
type, we studied endothelial cells. MT depolymerizing agents have
Figure 2. Microtubule dynamics are required for polarized distribution of F-actin. CCRF-CEM cells were pre-treated with or without taxol
or nocodazole, plated on ICAM-1, and then stimulated with 20 nM CXCL12 for 5 min. Cells were fixed and stained with anti-a-tubulin antibody
(green) and TRITC-conjugated phalloidin to show actin filaments (red). Representative confocal images are shown. Bar=10 mm. The white arrows in
nocodazole-treated cells indicate bleb-like membrane protrusions.
doi:10.1371/journal.pone.0008774.g002
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endothelial cells [49], but their effect on migration has not been
characterized. Human umbilical vein endothelial cells (HUVECs)
appear to be much more dependent on MTs for their migration
than T cells and neutrophils, since doses higher than 1 mM
induced membrane blebbing and completely abrogated cell
migration within one hour (data not shown). Lower doses of
nocodazole (0.2 mM) also induced membrane blebbing and
increased cell contraction (Figure 7A), but only partially inhibited
cell movement yet reduced cell displacement by 3.5 times as
compared with untreated control cells (Figure 7B,C). Time-lapse
movies showed that, like T cells, nocodazole-treated HUVECs
frequently changed direction (data not shown), accounting for the
lower cell displacement. Y-27632 partially rescued the defective
migration of nocodazole-treated HUVECs, resulting in longer cell
trajectories and a significant increase in cell displacement
(Figure 7C). Since the speed of cell migration was not significantly
different between nocodazole- and Y-27632/nocodazole-treated
HUVECs (Figure 7C), the recovery in cell displacement was
caused by a reduced turning frequency rather than an increase in
migration speed.
ROCK Inhibition Restores Cell Polarity in Nocodazole-
Treated T Cells
We next examined the effect of Y-27632 on cell polarization by
analysing the localization of F-actin, RhoA, phospho-ERMs, and
ICAM-3. As described above, most nocodazole-treated cells were
unable to form uropods and lamellipodia, and instead showed
multiple bleb-like protrusions where RhoA and phospho-ERMs
were enriched (Figure 8A, arrows). In contrast, cells treated with
Y-27632 and nocodazole formed uropods and lamellipodia with
polarized localization of phospho-ERMs at uropods in response to
CXCL12 stimulation (Figure 8A). Similarly, Y-27632 restored the
characteristic diametric distribution of F-actin and ICAM-3 upon
CXCL12 stimulation (Figure 8B, C). The same effect of Y-27632
was observed in a different cell polarization assay using ICAM-1-
and CXCL12-coated latex beads: Y-27632 restored diametric
distribution of F-actin and ICAM-3 in nocodazole-treated cells
(Figure 8D).
Rescue of Nocodazole Phenotype by Y-27632 Does Not
Involve PI3K/Akt Signaling
Since nocodazole inhibits the establishment of a stable leading
edge in T cells, and phosphoinositide 3-kinase (PI3K) activity is
enriched at the leading edge of a variety of cell types including
neutrophils [8], we determined whether PI3K activity was altered
in T cells treated with nocodazole. A read-out for PI3K activity is
Akt phosphorylation. Nocodazole decreased phospho-Akt levels
in CCRF-CEM cells (Figure S1B and C), as reported in
neutrophils [20]. In contrast, there was a marked increase in
phospho-Akt levels in Y-27632-treated cells. However, although
Y-27632 increased F-actin-rich lamellipodia in nocodazole-
treated cells (Figure 8B), it was not able to restore the levels of
phospho-Akt (Figure S1B and C), and thus the mechanism for
ROCK inhibitor-mediated restoration of a leading edge in
nocodazole-treated cells does not reflect increased activity of the
PI3K/Akt pathway.
ROCK Inhibition Stabilizes Microtubules
We assessed whether inhibition of ROCKs affects MT
distribution or stability, which could explain the protective effect
of Y-27632 on nocodazole-induced alterations in polarization and
migration. In HUVECs, low levels of nocodazole treatment for
60 min induced depolymerization of most MTs, leaving only
‘curly’ MTs around the nucleus (Figure 9A), which normally
represent more stable MTs [50,51]. Y-27632 alone did not affect
overall MT distribution. However, in HUVECs treated with Y-
27632 before addition of nocodazole, MTs appeared straighter
and longer (Figure 9A), suggesting that Y-27632 reduces
nocodazole-induced depolymerization of MTs.
In T cells, the level of stable MTs was investigated using
antibodies to acetylated tubulin and detyrosinated (Glu) tubulin,
which are indicators of stabilized MTs [26,52,53]. Over 50% of
CXCL12-stimulated T cells showed morphological polarization in
which acetylated MTs were concentrated in the uropod (Figure 9B,
C). Nocodazole treatment almost completely eliminated acetylated
MTs but approximately 40% of cells pre-treated with Y-27632
Figure 3. Effects of microtubule-disrupting agents on T-cell
polarization and F-actin levels. (A) Quantification of T cell
polarization. T cell morphology was classified in 3 categories: 1) non-
polarized (white), where the cells had a spherical morphology, 2)
elongated (gray), where the cells had an elongated cell shape but no
diametric polarization of F-actin and a-tubulin, and 3) migratory
polarized (black), where the cells were elongated and had diametric
distribution of F-actin at the leading edge and the MTOC (identified
with anti-a-tubulin antibody) behind the nucleus; n=110 to 150 cells
for each condition from 3 independent experiments. (B) Nocodazole
alters F-actin levels in T cells. Flow cytometric analysis of the F-actin
content of CCRF-CEM cells incubated with 10 mM Y-27632 for 30 min
and/or 20 mM nocodazole for 10 min. Data are shown as a percentage
of the mean fluorescence of untreated cells. Data are the mean of three
independent experiments +/2 SEM. *p,0.05 compared to control cells.
doi:10.1371/journal.pone.0008774.g003
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27632 also increased the total level of acetylated tubulin and Glu-
tubulin, both in control and nocadazole-treated cells, as assessed
by western blotting (Figure 9D). Since ROCKs are known to
stimulate MLC phosphorylation and hence myosin II activity, we
tested whether the myosin II inhibitor blebbistatin [54] affected
MTs. Interestingly, blebbistatin increased the level of acetylated
MTs in nocodazole-treated T cells similar to Y-27632, although it
did not rescue morphological polarity in T cells (Figure 9B,C) or
migration of nocodazole-treated HUVECs (data not shown).
Instead, T cells treated with blebbistatin and nocodazole either
had several protrusions in multiple directions or a spherical
morphology (Figure 9B; data not shown). This lack of polarity
could reflect a requirement for myosin II activity for stable
lamellipodial protrusion [55].
Discussion
MT depolymerization has been shown to reduce directional
migration in several cell types including human neutrophils and
zebrafish macrophages [19,21,56]. Here, we show that MT
depolymerization converts T cells from a lamellipodial/uropod
migratory phenotype to a blebbing migratory phenotype,
correlating with increased RhoA/ROCK activity. ROCK inhib-
itors prevent blebbing and restore lamellipodial/uropod polarity to
nocodazole-treated cells. In addition, we have found that ROCK
inhibitors and the myosin inhibitor blebbistatin protect MTs
against depolymerization. Our results support a model where
RhoA/ROCK signaling contributes to T cell polarization and
migration by regulating both contractility and MT stability
(Figure 10).
Figure 4. Microtubule-disrupting agents do not affect polarized clustering of uropod proteins. CCRF-CEM cells were pre-treated with or
without 10 mM taxol for 30 min or 20 mM nocodazole for 10 min, plated on ICAM-1, and then stimulated with 20 nM CXCL12 for 5 min before
fixation. (A) Cells were stained with anti-ICAM-3 antibody (green) and phalloidin to show actin filaments (red). Small uropod-like protrusions where
ICAM-3 accumulates in nocodazole-treated cells are indicated with white asterisks. Representative confocal images are shown. (B) Cells were stained
with anti-RhoA antibody (green) and anti-phospho-ERM antibody (red). Bleb-like membrane protrusions are indicated with white arrows and small
uropod-like protrusions where brighter phospho-ERM staining is observed are shown with white asterisks in nocodazole-treated cells. Bar=10 mm.
doi:10.1371/journal.pone.0008774.g004
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bleb-based migration in neutrophils [57] and bleb-like protrusions
in the KE-37 T-ALL cell line in suspension [58,59] or in a mouse
T cell line in agarose [60], but its effects on chemokine-stimulated
T cell migration or migratory polarity have not previously been
investigated. Our results indicate that MT depolymerization
reduces persistent migration of cells by increasing RhoA/ROCK
activity, which then interferes with stable migratory polarity by
causing membrane blebbing at multiple areas of the cell
membrane. RhoA/ROCK signaling also mediates blebbing
during apoptosis [61].
Our data demonstrate that ROCK inhibition with Y-27632
restores persistent migration in nocodazole-treated CCRF-CEM
cells and HUVECs, suggesting the molecular mechanisms linking
MTs and RhoA/ROCK are conserved in different types of cells.
Y-27632 has also been reported to repress the inhibitory effect of
nocodazole on the persistent migration of neutrophil-like HL60
cells in vitro [20] and on macrophage chemotaxis towards a
wound in zebrafish embryos [21]. We show for the first time that
Y-27632 can act both before and after nocodazole addition to
restore migratory persistence. This reflects the multiple actions of
RhoA/ROCK signaling in regulating both membrane blebbing
and MT stability. Myosin II inhibition with blebbistatin is well
known to inhibit membrane blebbing [61], and here we show that
it also affects MT stability. Myosin IIA deficiency and blebbistatin
have also been reported to stabilize MTs in fibroblasts [62].
However, myosin II inhibition is not able to restore migratory
polarity in nocodazole-treated T cells, and instead cells either have
multiple protrusions or a spherical morphology, and uropods are
rarely observed. These two phenotypes imply that myosin II
activity is required for both uropod formation and lamellipodial
protrusion in T cells, as previously suggested [3,63].
Although nocodazole inhibits uropod formation in T cells,
uropod proteins and RhoA still cluster on the plasma membrane.
This focal accumulation of uropod markers and RhoA could occur
initially through a positive feedback loop between RhoA and
Figure 5. Microtubule depolymerization induces RhoA activation. (A) Cells were pretreated with or without 10 mM taxol for 30 min and
subsequently with or without 20 mM nocodazole (noco) for 10 min, plated on ICAM-1 for 5 min, then lysed to determine the levels of active GTP-
bound RhoA by a GST-Rhotekin-RBD pulldown assay. The graph represents a quantification of densitometry results, normalised to total RhoA and
indicated as fold increase in RhoA-GTP over the level in control cells. Data shown are representative of 3 independent experiments. (B) CCRF-CEM
cells were pre-treated with (black) or without (white) 20 mM nocodazole (noco) for 10 min, plated on ICAM-1, then stimulated with 50 nM CXCL12 for
the indicated time periods. Levels of active GTP-bound RhoA were determined by a GST-Rhotekin-RBD pulldown assay. The graph represents a
quantification of densitometry results, normalised to total RhoA and indicated as fold increase in RhoA-GTP over the level in resting control cells
(0 min). Data shown are representative of 4 independent experiments. (C) Western blot of phospho-cofilin and total cofilin. CCRF-CEM cells were
treated with 10 mM Y-27632 (Y) for 30 min or 20 mM nocodazole (noco) for 10 min, plated on ICAM-1 then stimulated with 50 nM CXCL12 for 5 min,
lysed and analysed by western blotting using anti-phospho-cofilin (Ser3) antibody and cofilin antibody. Data represent quantification of densitometry
results from 3 independent experiments (Mean 6 SD), normalised to total cofilin and indicated as fold increase in phospho-cofilin over the level in
untreated control cells.
doi:10.1371/journal.pone.0008774.g005
Microtubules, T-Cell Migration
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would lead to phosphorylation and activation of ERM proteins,
which in turn bind to and cluster uropod receptors such as ICAM-
3. In the presence of MTs, RhoA activation of ROCK could
destabilize MTs locally at the uropod cortex, which could in turn
increase RhoA activity, probably through the release of a MT-
associated RhoGEF such as GEF-H1 [24]. This positive feedback
loop would establish strong RhoA/ROCK signaling in the uropod
but not elsewhere, allowing cells to establish a stable lamellipo-
dium and uropod and hence migrate persistently along one axis.
MT depolymerization induces high levels of RhoA/ROCK
activity at multiple points of the cell cortex, shifting cells from a
lamellipodium/uropod migratory polarity to a ROCK-mediated
membrane blebbing morphology with low migratory persistence
(Figure 10).
As well as preventing uropod formation, nocodazole inhibits the
establishment of a stable leading edge. Cofilin regulates lamelli-
podial extension and migratory polarity in breast carcinoma cells,
fibroblasts and T cells and its activity is inhibited by phosphor-
ylation [65–67]. The nocodazole-induced increase in cofilin
phosphorylation could therefore contribute to the loss of stable
polarity in T cells. Y-27632 inhibited the increase in cofilin
phosphorylation induced by nocodazole, indicating that ROCK is
a major regulator of cofilin phosphorylation in T cells, presumably
acting via LIMK [68]. This could contribute to the re-formation of
a stable leading edge by Y-27632 in nocodazole-treated cells.
Figure 6. The effect of nocodazole on T-cell migration is rescued by Y-27632. CCRF-CEM T cells were treated with or without 10 mMY -
27632 for 30 min and subsequently with or without 20 mM nocodazole (noco) for 10 min, then stimulated with 1 nM CXCL12 on ICAM-1-coated
dishes. (A) Cell migration was monitored by time-lapse microscopy. Examples of cell trajectories of 10 to 15 cells are shown and mean migration
speed 6 SEM (n=10–15). (B) Migration parameters were calculated from cell tracks. The kinetic data of 30 to 40 cells in each condition from three
independent experiments are shown. *p,0.05, compared to control cells, or
#p,0.05 compared to nocodazole-treated cells, indicated with bridges,
Student’s t-test. (C) Chemotaxis of CCRF-CEM cells towards CXCL12. Cells were pre-incubated with 10 mM Y-27632 for 30 min and/or 20 mM
nocodazole for the 10 min before adding to ICAM-coated transwells. Migrated cells were counted after 60 min. **p,0.01, compared to control cells,
or
#p,0.05 compared to nocodazole-treated cells, indicated with bridge, ANOVA. (D) CCRF-CEM cell migration was monitored by time-lapse
microscopy. Y-27632 (10 mM) was added to nocodazole-treated cells (20 mM) (noco) at 12 min (Movie S9; bottom panels). A control migrating cell is
marked with an asterisk (top panels). White arrow indicates a tail induced following Y-27632 addition; white arrowhead indicates restored
lamellipodium. Bar=10 mm.
doi:10.1371/journal.pone.0008774.g006
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uropods, ROCK might act in both locations.
RhoA has previously been reported to increase MT stability via
mDia1 but not ROCKs inquiescent fibroblasts following scratch
wounding [26]. Our observation that ROCK and myosin II
inhibitors affect MT stability and distribution in T cells and
endothelial cells suggests that ROCK signaling to MTs could be
dependent on cell type and/or culture conditions. How ROCK/
myosin II signal to MTs remains to be determined. It is possible
they act by regulating Rac and PAK [16,62], which are known to
induce phosphorylation and hence inhibition of the MT-
destabilizing protein stathmin/Op18 [29,69,70]. Indeed, Y-
27632 treatment increases phospho-stathmin levels in CXCL12-
stimulated CCRF-CEM cells (our unpublished data). Alternative-
ly, ROCK might directly affect enzymes that mediate tubulin
acetylation and detyrosination. De-acetylation of tubulin is
regulated by HDAC6 [71], and RhoA has been reported to
repress HDAC6 activity during Stat5-mediated transcription [72].
In summary, our data indicate that MT destabilization induces
loss of migratory polarity in T cells through RhoA/ROCK-
mediated disruption of lamellipodial/uropod migratory morphol-
ogy, and suggest that RhoA/ROCK signaling normally contrib-
utes to migration by affecting both actomyosin contractility and
MT stability.
Materials and Methods
Reagents
Recombinant human CXCL12/SDF-1a and ICAM-1/Fc
chimera were purchased from R&D Systems (Abingdon, UK).
Nocodazole, taxol (paclitaxel), FITC-conjugated anti-a-tubulin
antibody (DM1A), anti-acetylated tubulin antibody (6-11B-1) and
TRITC-conjugated-phalloidin were purchased from Sigma-Al-
drich (St. Louis, MO, USA), anti-phospho-Akt (Thr308 and
Ser473), anti-Akt, anti-phospho-ERM and anti-ERM, anti
phospho-cofilin (Ser3), anti-cofilin and anti-stathmin/Op18 anti-
bodies from Cell Signaling (Danvers, MA, USA), anti-ICAM3
antibody from Abcam (Cambridge, UK), anti-Glu-tubulin anti-
body from Chemicon (Chandlers Ford, UK), blebbistatin, Y-
27632 and H-1152 from Calbiochem (Nottingham, UK),
Alexa546-conjugated phalloidin, Alexa488, Alexa546-conjugated
goat anti-rabbit IgG (H+L) and Alexa488-conjugated goat anti-
mouse IgG (H+L) from Invitrogen (Paisley, UK), goat anti-rabbit
IgG (H+L)-HRP and goat anti-mouse IgG (H+L)-HRP from GE
Healthcare UK Limited (Bucks, UK), anti-phospho-stathmin/
Op18 (Ser16) and anti-RhoA antibody (26C4) from Santa Cruz
(Autogen Bioclear UK Ltd, Wiltshire, UK).
Cell Culture
CCRF-CEM cells, an acute T lymphoblastic leukemia cell line,
were purchased from ATCC (LGC Promochem, Middlesex, UK).
CCRF-CEM cells were cultured in RPMI 1640 medium with
2 mM L-glutamine containing 10% fetal calf serum, 10 mM
Hepes and 1 mM sodium pyruvate at 37uCi n5 %C O 2. Cells
were maintained at a density of between 2610
5 and 2610
6 cells/
ml and used for experiments at passage numbers less than 10. For
experiments with ICAM-1, culture dishes or coverslips were
coated with ICAM-1 (5 mg/ml) in phosphate-buffered saline (PBS)
at 4uC overnight. Plates were washed with PBS and blocked with
2.5% BSA in PBS for 2 h at 37uC. Human T lymphocytes were
prepared from single donor peripheral blood mononuclear
leukocytes by treatment with 0.5% phytohemagglutinin (PHA,
Sigma, Gillingham, UK) for 48 h. Cells were washed and cultured
in RPMI 1640 medium containing 10% human AB serum
(BioWest, Nuaille, France) and 10 U/ml interleukin-2 (IL-2,
Roche Diagnostics, Mannheim, Germany). Experiments were
performed after culturing the cells for 10 to 15 days. HUVECs
were purchased from Biowhittaker (Wokingham, UK) and
cultured in flasks coated with 10 mg/ml human fibronectin in
EGM-2 medium (Biowhittaker) supplemented with 2% fetal calf
serum. For motility analysis and immunostaining, HUVECs were
plated at a density of 2610
4 cells/ml in 9 cm
2 Nunc slide flasks
(Invitrogen, Paisley,UK) on glass coverslips coated with 10 mg/ml
human fibronectin.
Time-Lapse Microscopy
CCRF-CEM cells were incubated in migration medium (PBS
containing 20 mM Hepes pH 7.0 and 0.5% BSA) at 10
6 cells/ml
for 2 hours at 37uC, 5% CO2. Cells were then treated with or
without 10 mM taxol or 10 mM Y-27632 for 30 min and
subsequently treated with or without the indicated concentrations
of nocodazole for 10 min. 10
6 cells were added to ICAM-1-coated
35-mm plastic culture dishes (Nunc) or glass bottom culture dishes
(MatTek). After 5 min, non-adherent cells were removed, and pre-
warmed fresh migration medium with or without the same
concentrations of taxol, Y-27632 or nocodazole was added. Cells
Figure 7. Y-27632 rescues the effect of nocodazole on
endothelial cell migration. (A) Nocodazole induces membrane
blebbing in HUVECs. Nocodazole (noco, 0.2 mM) was added to HUVECs
for 30 min, then cells were fixed and stained with phalloidin to show
actin filaments. (B) Y-27632 rescues the effect of nocodazole on HUVEC
migration. Y-27632 (Y, 5 mM) and 0.2 mM nocodazole (noco) were added
to HUVECs 15 min before the acquisition of time-lapse movies. The
migration tracks of 90 to 100 cells from three independent experiments
were analysed. Examples of cell trajectories of 30 cells in each condition
are shown. (C) Migration parameters for HUVECs were calculated from
cell tracks; % of control displacement and migration speed were
evaluated from cells that had migrated a distance of 50 mm or more
from the starting point during 5 h in (B). *p,0.05, compared to control
cells, or
#p,0.05 compared to nocodazole-treated cells, indicated with
bridges, Student’s t-test.
doi:10.1371/journal.pone.0008774.g007
Microtubules, T-Cell Migration
PLoS ONE | www.plosone.org 9 January 2010 | Volume 5 | Issue 1 | e8774Figure 8. Y-27632 restores migratory polarity to nocodazole-treated cells. (A) CCRF-CEM cells were treated with or without 10 mM Y-27632
(Y) and 20 mM nocodazole (noco) then plated on ICAM-1 and stimulated with 20 nM CXCL12 for 5 min. Cells were fixed and stained with anti-RhoA
antibody (green) and anti-phospho-ERM antibody (red). Representative confocal projection images reconstructed from z-stacks of 15 to 25 frames
with 0.4 mm interval are shown. Note that Y-27632 prevents nocodazole-induced membrane blebbing (indicated with white arrows) and restricts
phospho-ERMs to the uropod. Bar=10 mm. (B) Localization of F-actin (red) and ICAM-3 (green) in CXCL12-stimulated CCRF-CEM cells on ICAM-1. Cells
were pre-treated with 20 mM nocodazole (noco) and 10 mM Y-27632 (Y) as indicated. Representative confocal images and line-plot graphs of
subcellular distributions of F-actin and ICAM-3 in each condition. Line-plot graphs indicate fluorescent intensity (FI) of phalloidin (F-actin) (red) and
ICAM-3 (green) along the white arrows indicated in merge images. (C) Percentage of CCRF-CEM cells with diametric polarization of F-actin and ICAM-
3. Data are from n=220 to 250 cells in each condition which are collected from 3 independent experiments and represent mean 6 SD. *p,0.03,
compared to control cells, Student’s t-test. (D) CCRF-CEM cells were treated with or without 10 mM Y-27632 (Y) for 30 min and subsequently with or
without 20 mM nocodazole (noco) for 10 min, incubated with latex-beads coated with ICAM-1 (5 mg/ml) and CXCL12 (20 nM), and then fixed and
stained with phalloidin to show actin filaments (red) and anti-ICAM-3 antibody (green). Representative images are shown. Asterisks indicate the bead-
cell contact sites.
doi:10.1371/journal.pone.0008774.g008
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PLoS ONE | www.plosone.org 10 January 2010 | Volume 5 | Issue 1 | e8774Figure 9. ROCK inhibitors increase microtubule stability. (A) HUVECs were left untreated (control) or were incubated with 0.1 mM nocodazole
for 60 min (noco) and/or 5 mM Y-27632 (Y) for 15 min then 0.1 mM nocodazole for 60 min (Y+noco). To visualize MT distribution, cells were extracted
with 0.05% Triton X-100 to remove monomeric tubulin, then stained with anti-a-tubulin antibodies. The areas marked with a white rectangle have
been enlarged and pseudocoloured using the image analysis program LaserPix to help visualise MT morphology in untreated and treated cells. (B, C)
CCRF-CEM cells were treated with or without 10 mM Y-27632 (Y), 0.4 mM H-1152 (H) or 50 mM blebbistatin (bleb) for 30 min, then with or without
20 mM nocodazole (noco) for 10 min, then plated on ICAM-1 and stimulated with 20 nM CXCL12 for 5 min. Localization of acetylated tubulin (Ace-
TUB) was examined by staining with anti-Ace-TUB antibody. (B) Representative confocal images; the outline of cells is indicated by white lines; (C)
percentage of filamentous Ace-TUB positive cells (top), and % of morphologically polarized cells (with uropod and a leading edge) containing
filamentous Ace-TUB (bottom). Data represent mean 6 SEM from 3 independent experiments, n=150 to 250 cells in each condition,
##p,0.01 for %
of Ace-TUB positive cells compared to nocodazole-treated cells in the top panel, **p,0.01 for % of morphologically polarized cells compared to
untreated control, or
#p,0.05 compared to nocodazole-treated cells, to Y-27632+nocodazole-treated cells or to H-1152+nocodazole-treated cells
(indicated with bridge), Student’s t-test. (D) Western blot analysis of Ace-TUB and Glu-TUB levels in CCRF-CEM T cell lysates treated with or without
10 mM Y-27632 (Y) for 30 min and subsequently with or without 20 mM nocodazole (noco) for 10 min. Data represent quantification of densitometry
results (Mean 6 SD) of three independent experiments, normalised to the total a-TUB level and indicated as fold increase in Ace-TUB or Glu-TUB over
the level in control cells; *p,0.05, **p,0.01 for Ace-TUB, or
#p,0.05,
#p,0.01 for Glu-TUB compared to control (without bridge), or to nocodazole-
treated cells (indicated with bridge); Student’s t-test.
doi:10.1371/journal.pone.0008774.g009
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with a heated stage and CO2 circulator to maintain cells at 37uC
and 5% CO2. Where indicated, cells were stimulated with 1 nM
CXCL12. HUVECs were incubated in EGM-2 medium and
plated at 2610
4 cells/ml in 9 cm
2 Nunc slide flasks on glass
coverslips coated with 10 mg/ml human fibronectin. Cells were
treated with Y-27632 (5 mM) and/or nocodazole (0.2 mM) for
15 min prior to imaging. Cell migration was monitored by time-
lapse microscopy, acquiring a frame every 15 s for a period of
30 min (CCRF-CEM cells) or every 10 min for 5 h (HUVECs).
For high-resolution analysis of membrane blebbing, 1.5610
5
CCRF-CEM cells or T-lymphoblasts in RPMI containing 10%
serum were plated onto ICAM-1-coated glass bottom dishes. After
15 min, non-adherent cells were washed off. Where indicated,
nocodazole (20 mM) was added, and then cells were imaged by
time-lapse microscopy, acquiring 1 frame/s for up to 10 min.
Cells were tracked with Kinetic Imaging software (Andor
Technology, Belfast, UK) and the trajectories were analyzed
statistically using Mathematica software (Wolfram Research Inc,
Champaign, IL). To obtain reliable values for kinetic data for
CCRF-CEM cells, we collected cells in each condition whose total
migration distance in 30 min was between 120–200 mm. There
was no significant difference in the % of cells migrating this
distance with the different treatments tested (none (n=25): 43%;
nocodazole (n=29): 39%; nocodazole +Y-27632 (n=30): 38%).
CCRF-CEM cells that migrated less than 120 mm were not
included because cells that are mostly stationary can artificially
reduce persistence. For HUVECs, cell displacement was evaluated
by calculating the percentage of the total cells analysed that had
migrated a distance of 50 mm or more from the starting point
during 5 h in each experiment.
Transwell Chemotaxis Assay
CCRF-CEM cells (2610
5 cells/transwell) were incubated in
growth medium alone or in medium with 10 mM Y-27632 for
30 min and/or 20 mM nocodazole for 10 min before adding (in
200 ml) to ICAM-1-coated transwells (24-well; 5-mm pore size)
containing growth medium and 10 mM Y-27632 and/or 20 mM
nocodazole in both wells and 30 ng/ml CXCL12 in the bottom
well. After 1 h, cells in the bottom well were counted with a cell
counter (CASY). Each experimental condition was carried out in
triplicate in each experiment.
RhoA Activity Assays
GST-Rhotekin-RBD protein was purified from E. coli by
resuspending the bacterial pellet in ice-cold STE buffer (10 mM
Tris (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1 mM PMSF),
incubating with 100 mg/ml lysozyme for 15 min on ice, and then
adding 5 mM DTT, 1% Tween-20 and 0.03% SDS sequentially.
The lysate was clarified by centrifugation and GST-Rhotekin-
RBD was purified by incubating with glutathione-sepharose 4B
beads (GE Healthcare UK Limited) for 10 min at room
temperature or 1 h at 4uC. Beads were washed three times with
cold STE buffer.
For RhoA pulldowns, CCRF-CEM cells were pre-incubated in
low-serum RPMI containing 0.1% FCS and 25 mM Hepes
overnight, and 10 to 15610
6 cells were resuspended in 250 ml low-
serum RPMI. Cells were treated with or without nocodazole and
Y-27632 as described above, then added to an ICAM-1-coated 25-
mm well, incubated for 5 min, then stimulated with or without
50 nM CXCL12 for the time periods indicated in the figure
legend. For Figure 5A, 10 to 15610
6 cells of CCRF-CEM cells
were directly suspended in 10% serum containing RPMI without
serum starvation, then treated with or without taxol and
nocodazole as described above and used for RhoA pulldown
assay. Cells were immediately lysed in ice-cold lysis buffer
containing 25 mM Hepes pH 7.5, 150 mM NaCl, 1% NP-40,
10 mM MgCl2, 1 mM EDTA, 25 mM NaF, 1 mM Na3VO4,
10 mg/ml aprotinin, 100 mM PMSF and 10% glycerol. The lysates
were clarified by centrifugation. Supernatants were incubated with
GST-Rhotekin-RBD beads (,30 mg/reaction) for 1 h at 4uC and
then the beads were washed 3 times with cold lysis buffer. Bound
GTP-RhoA was detected by western blotting using monoclonal
anti-RhoA antibody (1:1000).
Flow Cytometric Analysis of F-Actin Content
CCRF-CEM cells were suspended at 10
7/ml in RPMI
containing 20 mM Hepes and 0.5% BSA and incubated for 1 h
at 37uC. Where indicated, cells (10
6 cells/treatment) were incubat-
ed in medium alone or in the presence of 10 mM Y-27632 for the
last 30 min and/or 20 mM nocodazole for the last 10 min. Cells
werethenfixedatroomtemperaturefor10 minbyadding200 mlo f
4% paraformaldehyde, washed in PBS containing 0.5% BSA
(FACS buffer), then permeabilized in0.1%Triton X-100 inPBSfor
4 min. Cells were washed in FACS buffer and then incubated for
30 min at room temperature in 100 ml of Alexa488-labelled
phalloidin (2 mg/ml; Molecular Probes) diluted in FACS buffer.
Cells were then washed twice in FACS buffer. 10,000 events were
acquired per sample on a Becton Dickinson FACSCalibur and
analysed using Cell Quest software. Data are expressed as a
percentage of the mean fluorescence of untreated cells.
Immunofluorescence
CCRF-CEM cells were incubated in serum-free RPMI
containing 25 mM Hepes at 2610
6 cells/ml for 3 h at 3uC, 5%
Figure 10. Model for roles of microtubules and ROCKs in T-cell
polarity and migration. (A) T cell migration is stimulated by CXCL12.
Migrating T cells have a lamellipodium at the front and uropod with
uropod-localized proteins (e.g. ICAM-3, phosphorylated ERM proteins)
at the back. Our results suggest that ROCKs reduces MT stability in the
uropod and could inhibit cofilin activity in the lamellipodium. (B)
Microtubule (MT) depolymerization, for example by nocodazole,
releases a RhoGEF for RhoA, which increases the level of GTP-bound
active RhoA. RhoA then stimulates ROCKs, which stimulate contractility
and membrane blebbing and decreases microtubule stability. Inhibition
of ROCKs reduces blebbing, increases stable MT, and reduces cofilin
phosphorylation, thereby restoring lamellipodial/uropod polarity.
doi:10.1371/journal.pone.0008774.g010
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20 mM nocodazole or 10 mM Y-27632 as described above, then
plated on ICAM-1-coated coverslips or Lab-Tek slide chambers.
After 5 min, cells were stimulated with or without 20 nM
CXCL12 for 5 min. To analyse T cell polarization, cells were
fixed with 4% paraformaldehyde for 10 min. For total RhoA or
phospho-ERM localization, cells were fixed with 10% trichlor-
oacetic acid for 15 min on ice. For Acetylated tubulin or Glu-
tubulin staining, cells were fixed with pre-warmed 4% formalde-
hyde in PBS containing 2 mM MgCl2 and 1 mM EGTA at 37uC
for 10 min, then treated with cold methanol at 220uC for 5 min.
Cells were permeabilized with 0.1% Triton X-100 for 4 min and
blocked with 1% BSA in PBS for 1 h at room temperature. Cells
were incubated with 1:400 Alexa546- or TRITC-labeled phalloi-
din, FITC-conjugated anti-a-tubulin (1:300), anti-acetylated
tubulin (1:200), anti-Glu tubulin (1:200), anti-ICAM-3 (1:50),
anti-RhoA (26C4) (1:50) and/or anti-phospho-ERM (1:100)
antibodies for 1 h then with FITC- or TRITC-labeled mouse or
rabbit IgG antibodies for 1 h. Images were acquired with a
Photonic Science cooled CCD camera (Robertsbridge, UK)
mounted on a Zeiss Axiophot microscope equipped with a 100x
oil objective using ImagePro software or a LSM510 confocal
microscope (Zeiss, Oberkochen, Germany) with a 40x oil
objective.
To visualize stable MT in HUVECs, cells were pre-extracted to
remove unpolymerized tubulin using a method modified from
Gundersen et al. [73]. Briefly, HUVECs were rapidly washed in
microtubule stabilizing buffer (MSB) (85 mM Pipes, pH 6.93,
1 mM EG’I’A, 1 mM MgCl2, 2 M glycerol, and protease
inhibitors: 10 mg/ml aprotinin, 0.5 mM benzamidine, 5 mg/ml
o-phenanthroline, and 0.2 mM PMSF) and then extracted with
MSB containing 0.05% Triton X-100. After 2 min, cells were
gently washed in MSB and fixed with methanol at 220uC. The
cells were then washed in PBS, blocked with 1% BSA in PBS for
1 h then incubated with mouse anti-a-tubulin antibodies (Sigma-
Aldrich), followed by TRITC-labeled goat anti-mouse antibodies.
Cells were mounted in Vectashield mounting medium (Vector
Laboratories Inc, CA) and examined by confocal microscopy (Bio-
Rad Radiance 2100) with Bio-Rad software (LaserSharp 2000
version 5.1). LaserPix software (Bio-Rad) was used to pseudocolor
MTs in images.
Western Blotting
CCRF-CEM cells (10
7 cells/condition) were incubated in low-
serum RPMI for 3 h at 37uC, 5% CO2. Cells were treated with
10 mM Y-27632 and/or 20 mM nocodazole as indicated. Cells
were plated on ICAM-1-coated dishes and incubated for 10 min.
Cells were then stimulated with 50 nM CXCL12 for 10 min, and
lysed in 100 ml of PBS containing 1% SDS. Subsequently 500 mlo f
PBS containing 1% Triton-X100, 25 mM NaF, 1 mM Na3VO4,
10 mg/ml aprotinin and 100 mM PMSF was added, and lysates
were incubated on ice for 10 min, homogenized with a 25-gauge
needle, and clarified by centrifugation. To detect acetylated and
detyrosinated (Glu-) tubulin, cells were lysed as above except that
pre-warmed (37uC) MT stabilisation buffer (85 mM PIPES
pH 6.9, 1 mM EGTA, 1 mM MgCl2 and 2 M Glycerol) was
used instead of PBS and lysates were not incubated on ice.
Samples were analysed by SDS-PAGE followed by western
blotting.
Supporting Information
Figure S1 (A) F-actin (green) and CD44 (red) localization in
control (left panel) and nocodazole-treated (right panel; 20 mM,
10 min) CCRF-CEM cells stimulated with 20 nM CXCL12 for
5 min. Asterisk indicates CD44 clustering in a small uropod-like
protrusion, arrowhead indicates a bleb-like structure that does not
contain CD44. (B, C) Western blots of phospho-Akt (Thr308) and
(Ser473) levels. CCRF-CEM cells were pre-treated with or without
10 mM Y-27632 before addition of 20 mM nocodazole, then
stimulated with 50 nM CXCL12 for 5 min on ICAM-1. The
graph for phospho-Akt (Thr308) (B) represents quantification of
densitometry results obtained from 3 independent experiments
(Mean 6 SD), normalised to total Akt and indicated as fold
increase over the resting control condition. *p,0.05, compared to
control CXCL12-stimulated cells, Student’s t-test. The graph in
(C) represents a quantification of densitometry results, normalised
to total Akt and indicated as fold increase over the resting control
condition. Similar data were obtained in three independent
experiments.
Found at: doi:10.1371/journal.pone.0008774.s001 (7.21 MB TIF)
Movie S1 CCRF-CEM T cells stimulated with 1 nM CXCL12
on ICAM-1; 1 frame/15 sec.
Found at: doi:10.1371/journal.pone.0008774.s002 (2.74 MB
MOV)
Movie S2 Taxol-treated (10 mM for 30 min) CCRF-CEM cells
stimulated with 1 nM CXCL12 on ICAM-1; 1 frame/15 sec.
Found at: doi:10.1371/journal.pone.0008774.s003 (2.47 MB
MOV)
Movie S3 Nocodazole-treated (20 mM for 10 min) CCRF-CEM
cells stimulated with 1 nM CXCL12 on ICAM-1; 1 frame/15 sec.
Found at: doi:10.1371/journal.pone.0008774.s004 (2.48 MB
MOV)
Movie S4 CCRF-CEM cell on ICAM-1; 1 frame/sec.
Found at: doi:10.1371/journal.pone.0008774.s005 (2.55 MB
MOV)
Movie S5 Nocodazole-treated (20 mM) CCRF-CEM cell on
ICAM-1; 1 frame/sec. Note progressive membrane blebs extend
in the same area of the membrane, causing forward protrusion.
Found at: doi:10.1371/journal.pone.0008774.s006 (5.05 MB
MOV)
Movie S6 Human T-lymphoblasts on ICAM-1; 1 frame/sec.
Found at: doi:10.1371/journal.pone.0008774.s007 (4.80 MB
MOV)
Movie S7 Nocodazole-treated (20 mM) human T-lymphoblasts
on ICAM-1; 1 frame/sec. Note progressive membrane blebs
extend in the same area of the membrane.
Found at: doi:10.1371/journal.pone.0008774.s008 (1.22 MB
MOV)
Movie S8 Nocodazole-treated (20 mM for 10 min) CCRF-CEM
cells stimulated with 1 nM CXCL12 on ICAM-1. Y-27632
(10 mM) was added to nocodazole-treated cells at 12 min; 1
frame/15 sec. Nocodazole induces membrane blebbing, which is
inhibited by the addition of Y-27632, followed by the establish-
ment of a lamellipodium and membrane ruffling at the leading
edge and a stable uropod.
Found at: doi:10.1371/journal.pone.0008774.s009 (5.90 MB
MOV)
Movie S9 Nocodazole-treated (20 mM for 10 min) CCRF-CEM
cells stimulated with 1 nM CXCL12 on ICAM-1. Y-27632
(10 mM) was added to nocodazole-treated cells at 12 min; 1
frame/15 sec. Nocodazole induces membrane blebbing, which is
inhibited by the addition of Y-27632, followed by the establish-
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edge and a stable uropod.
Found at: doi:10.1371/journal.pone.0008774.s010 (3.27 MB
MOV)
Movie S10 Nocodazole-treated (20 mM for 10 min) CCRF-
CEM cells stimulated with 1 nM CXCL12 on ICAM-1; 1 frame/
15 sec.
Found at: doi:10.1371/journal.pone.0008774.s011 (2.20 MB
MOV)
Movie S11 Y-27632- (10 mM for 30 min) and nocodazole-
treated (20 mM for 10 min) CCRF-CEM cells stimulated with
1 nM CXCL12 on ICAM-1; 1 frame/15 sec. Arrows indicate
examples of cells with elongated tails, which eventually detached
from the ICAM-1-coated dish to move forward.
Found at: doi:10.1371/journal.pone.0008774.s012 (2.09 MB
MOV)
Movie S12 Y-27632-treated (10 mM for 30 min) CCRF-CEM
cells stimulated with 1 nM CXCL12 on ICAM-1; 1 frame/15 sec.
Found at: doi:10.1371/journal.pone.0008774.s013 (2.94 MB
MOV)
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